Title: Mass Drug Administration Coverage Evaluation for Elimination of Lymphatic Filariasis in Nagpur District of Maharashtra
Authors: Dr Ashok Rupraoji Jadhao, Dr Durgesh Prasad Sahoo, Dr Jyotsna Sukhdeo Deshmukh, Dr Roshan Umedlal Raut, Dr Anchlesh Vinod Tekam
DOI: https://dx.doi.org/10.18535/jmscr/v5i9.144
Abstract
Introduction: Lymphatic filariasis is an important public health problem in India. Nagpur district In Maharashtra is one of the endemic district where Mass drug administration activity is undertaken every year to eliminate lymphatic filariasis.
Objectives: To evaluate mass drug administration for elimination of lymphatic filariasis in terms of actual coverage, compliance rates of MDA, the reasons for non-compliance and drug related side effects in Nagpur district.
Methods: The guidelines of National Vector Borne Disease Control Programwas used to select a total of 120 households from three villages and one urban town using two stage random sampling method. 30 households were covered in each clusters and data was collected using predesigned questionnaire. Data was analyzed manually and z score was calculated using z score calculator.
Results: A total of 120 households were surveyed in Nagpur district with a population coverage of 589. The present study revealed population coverage of 81.66%, compliance rate of 95.24%, Coverage Compliance Gap of 4.76% and effective coverage of 77.78%. Rural area had better effective coverage as compared to urban area (Z score =9.732, p value =0.00018).
Conclusion: In spite of average coverage in Nagpur district, widespread rural-urban variation in performance status, lack of supervised drug dosing revealed by the present study is remain the important areas of concern. Both drug coverage and compliance needs to be improved. Stress to be given in urban area for better compliance.
Keyword: Mass drug administration, Coverage rate, Compliance rate, Coverage Compliance Gap, Effective coverage rate.
References
- WHO | Epidemiology. WHO [Internet]. 2016 [cited 2017 Sep 18]; Available from: http://www.who.int/lymphatic_filariasis/epidemiology/en/
- Programme NVBD. Guidelines on Elimination of Lymphatic Filariasis India. 2014;1–108.
- NVBDCP | National Vector Borne Disease Control Programme [Internet]. [cited 2017 Sep 18]. Available from: http://nvbdcp.gov.in/fil5.html
- of India (2002). National Health Policy - 2002. Dep Heal Minist Heal Fam Welf [Internet]. 2002;1–36. Available from: http://mohfw.nic.in/WriteReadData/l892s/18048892912105179110National Health policy-2002.pdf
- A. O, B.O.L. D, Karam M, Behbehani K. Strategies and tools for the control / elimination of lymphatic filariasis. Bull World Health Organ. 1997;75(4):491–503.
- NVBDCP | National Vector Borne Disease Control Programme - MDA Coverage [Internet]. [cited 2017 Sep 21]. Available from: http://www.nvbdcp.gov.in/fil-mda.html
- Z Score Calculator for 2 Poulation Proportions [Internet]. [cited 2017 Sep 19]. Available from: http://www.socscistatistics.com/tests/ztest/Default2.aspx
- Marathe N, Chalisgaonkar C. Mass drug administration coverage evaluation for elimination of lymphatic filariasis in Chhatarpur district of Madhya Pradesh. Int J Med Sci Public Heal [Internet]. 2015;4(7):927–32. Available from: http://www.scopemed.org/fulltextpdf.php?mno=181856
- Chinte L T, Holambe V M DJV. A study on coverage evaluation, compliance and awareness of mass drug administration for elimination of lymphatic filariasis in Latur district. MedPulse Int J Community Med [Internet]. 2017;2(1):06–8. Available from: https://www.medpulse.in/Community Medicine/Article/Volume2Issue/CM_2_1_2.pdf
- Godale LB, Ukarande B V. a Study on Coverage Evaluation, Compliance and Awareness of Mass Drug Administration for Elimination of Lymphatic Filariasis in Osmanabad District. Natl J Community Med [Internet]. 2012;3(3):391. Available from: https://liverpool.idm.oclc.org/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=edb&AN=83333193&site=eds-live&scope=site
- Lahariya C, Mishra A. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: An evaluation study. J Vector Borne Dis. 2008;45(4):313–20.
- Jothula KY, Naidu NK, Malhotra VM, Prasad VG, Kabra PR, Nagaraj K. Evaluation of mass drug administration programme for elimination of lymphatic filariasis in Nalgonda district , Telangana , India. 2016;3(8):2008–12.
- Bhatia M, Dwivedi V, Bhargo L, Mahajan PC. A Quantitative and Qualitative Evaluation of Mass Drug Administration (MDA) program in three districts of Madhya Pradesh (India). Asian Pac J Heal Sci ASIAN PACIFIC J Heal Sci. 2014;1(14S):63–70.
- Havale NG. Evaluation of coverage and compliance of elimination of lymphatic filariasis by mass drug administration campaign in Gulbarga and Yadgiri districts of Karnataka state. 2015;3(8):2105–8.
- Patel P. Mass drug administration coverage evaluation survey for lymphatic Filariasis in Bagalkot and Gulbarga districts. Indian J Community Med [Internet]. 2012;37(2):101. Available from: http://www.ijcm.org.in/text.asp?2012/37/2/101/96095
- Ghosh S, Samanta A, Kole S. Mass drug administration for elimination of lymphatic filariasis: Recent experiences from a district of West Bengal, India. Trop Parasitol [Internet]. 2013;3(1):67–71. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3745675&tool=pmcentrez&rendertype=abstract
- G. Perni, D.D. Motghare, A.M. Ferreira1, S.S. Perni, F.S. Vaz, M.S. Kulkarni1 SG. Evaluation of mass drug administration for elimination of lymphatic filariasis in Goa, India. Int J Community Med Public Heal. 2015;2(3):259–62.
- Ranganath TS. Original Article- COVERAGE EVALUATION OF MASS DRUG ADMINISTRATION FOR ELIMINATION OF LYMPHATIC FILARIASIS IN KARWAR DISTRICT OF KARNATAKA. BMCRI J. 2012;
- V G Prasad, V M Malhotra, Kishore Yadav J, Kranti Prasad KN, Dept. Evaluation of Mass Drug Administration Programme for Elimination of Lymphatic Filariasis in Nalgonda District of Telangana. JInternational J Heal Sci Res [Internet]. 2015;5(5):11–6. Available from: http://www.ijhsr.org/IJHSR_Vol.5_Issue.5_May2015/2.pdf